Please note: This event will be held in Dutch.
Medical Delta Café on bioscience, precision diagnostics and personalized medicine
Metabolic profiles are helping us better understand which treatments or medications are most effective for a specific condition and individual. In the future, we may even be able to identify the most effective health interventions before a disease develops, helping to slow down or prevent disease progression and ageing. Advanced analyses of enormous datasets are also providing deeper insights into the cellular processes involved in the development of brain diseases and how we can intervene in these processes in a targeted way.
These are examples of important advances in biotechnology, molecular diagnostics, AI and digital healthcare. They are paving the way for earlier diagnoses, more precise treatment choices, continuous monitoring and better patient outcomes. These developments bring us closer to proactive, personalised healthcare and prevention, with health technologies and precision diagnostics playing an increasingly important role.
Are we on the brink of a revolution?
Are these developments the first signs of a revolution in medicine? Or are there still too many uncertainties for them to be widely applied in clinical practice? What barriers still need to be overcome, and how can we accelerate this process?
We will discuss these questions at Rijksmuseum Boerhaave in Leiden with three leading scientists, each working in their own field on breakthroughs that could have a major impact on medicine and healthcare.
About the speakers
- Prof. dr. Thomas Hankemeijer (Leiden University, Erasmus MC) integrates extensive molecular data with clinical information, lifestyle data and population health information. This enables healthcare professionals to gain a much deeper understanding of early disease processes and how patients respond to interventions.
- Prof. dr. Eline Slagboom (LUMC, TU Delft) investigates how so-called metabolites in the blood can predict the risk of physical frailty, certain diseases and multimorbidity. In the future, such biological profiles could be measured more frequently to link established risks to proven effective interventions that contribute to better health.
- Prof. dr. Boudewijn Lelieveldt (LUMC, TU Delft) is part of a large international consortium, including the Allen Institute, working to build a detailed atlas of different cell types in the brain. This extensive, multi-year research could help us better understand how brain diseases develop and how we can prevent, diagnose and treat them more effectively.
All three scientists hold Medical Delta Professor positions, with appointments at multiple universities in South Holland. You can therefore expect interdisciplinary perspectives that bridge science, technology and healthcare practice.
Practical information
- Date: Thursday, November 12th, 16:00-17:15
- Location: Rijksmuseum Boerhaave, Leiden
- Language: This event will be held in Dutch.
- Register via this link.
